For research use only. Not for therapeutic Use.
Mal-Deferoxamine is the linker for construct RDC[1].
| Catalog Number | I045320 |
| CAS Number | 1638156-31-6 |
| Synonyms | N-[5-[acetyl(hydroxy)amino]pentyl]-N’-[5-[[4-[5-[3-(2,5-dioxopyrrol-1-yl)propanoylamino]pentyl-hydroxyamino]-4-oxobutanoyl]amino]pentyl]-N’-hydroxybutanediamide |
| Molecular Formula | C32H53N7O11 |
| Purity | ≥95% |
| InChI | InChI=1S/C32H53N7O11/c1-25(40)37(48)21-8-2-5-18-33-26(41)11-13-31(46)38(49)22-9-3-6-19-34-27(42)12-14-32(47)39(50)23-10-4-7-20-35-28(43)17-24-36-29(44)15-16-30(36)45/h15-16,48-50H,2-14,17-24H2,1H3,(H,33,41)(H,34,42)(H,35,43) |
| InChIKey | WVJJZZJONDZKRF-UHFFFAOYSA-N |
| SMILES | CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCN1C(=O)C=CC1=O)O)O)O |
| Reference | [1]. Summer D, et al. Cyclic versus Noncyclic Chelating Scaffold for 89Zr-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression. Mol Pharm. 2018;15(1):175-185. |
